Infusion Therapy Market (Product: Infusion Pumps, Infusion Set, and Accessories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Jan 2023| TMR3502A| Transparency

Report Highlights

Infusion Therapy Market – Scope of Report

TMR’s report on the global infusion therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global infusion therapy market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global infusion therapy market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the infusion therapy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global infusion therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global infusion therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global infusion therapy market.

The report delves into the competitive landscape of the global infusion therapy market. Key players operating in the global infusion therapy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global infusion therapy market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market infusion therapy.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
    • WorldWideScience.org
    • Elsevier, Inc.
    • National Institutes of Health (NIH)
    • PubMed
    • NCBI
    • Department of Health Care Service
  • Trade Data Sources
    • Trade Map
    • UN Comtrade
    • Trade Atlas
  • Company Information
    • OneSource Business Browser
    • Hoover’s
    • Factiva
    • Bloomberg
  • Mergers & Acquisitions
    • Thomson Mergers & Acquisitions
    • MergerStat
    • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2022-2031
Growth rate 6.70%
Units considered $ Billion
Segments covered By Product, By Infusion Pumps, By Indication, By End User, By Therapy, By Region
Industry covered Healthcare
Countries covered North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Companies studied
  • B. Braun Melsungen AG,
  • Becton, Dickinson and Company,
  • Medtronic plc.
  • ICU medical (Smiths Medical),
  • Baxter International, Inc.,
  • Polymedicure,
  • Terumo Medical Corporation,
  • BIO-MED,
  • MEDIPRIM GmbH,
  • Fresenius Kabi,
  • Cardinal Health

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Global Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031
  • Table 2 : Global Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031
  • Table 3 : Global Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031
  • Table 4 : Global Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
  • Table 5 : Global Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031
  • Table 6 : Global Infusion Therapy Market Value (US$ Bn) Forecast, by Region, 2017–2031
  • Table 7 : North America Infusion Therapy Market Value (US$ Bn) Forecast, by Country, 2017–2031
  • Table 8 : North America Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031
  • Table 9 : North America Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031
  • Table 10 : North America Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031
  • Table 11 : North America Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
  • Table 12 : North America Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031
  • Table 13 : Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
  • Table 14 : Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031
  • Table 15 : Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031
  • Table 16 : Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031
  • Table 17 : Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
  • Table 18 : Europe Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031
  • Table 19 : Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
  • Table 20 : Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031
  • Table 21 : Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031
  • Table 22 : Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031
  • Table 23 : Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
  • Table 24 : Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031
  • Table 25 : Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
  • Table 26 : Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031
  • Table 27 : Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031
  • Table 28 : Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031
  • Table 29 : Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
  • Table 30 : Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031
  • Table 31 : Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
  • Table 32 : Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031
  • Table 33 : Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031
  • Table 34 : Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031
  • Table 35 : Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
  • Table 36 : Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031
  • Figure 1 : Global Infusion Therapy Market Value Share, by Product, 2021 and 2031
  • Figure 2 : Global Infusion Therapy Market Attractiveness Analysis, Product, 2022–2031
  • Figure 3 : Global Infusion Therapy Market (US$ Bn), by Infusion Pumps, 2017–2031
  • Figure 4 : Global Infusion Therapy Market (US$ Bn), by Infusion Set, 2017–2031
  • Figure 5 : Global Infusion Therapy Market (US$ Bn), by Accessories, 2017–2031
  • Figure 6 : Global Infusion Therapy Market, by Indication, 2021 and 2031
  • Figure 7 : Global Infusion Therapy Market Attractiveness Analysis, Indication, 2022–2031
  • Figure 8 : Global Infusion Therapy Market (US$ Bn), by Cancer, 2017–2031
  • Figure 9 : Global Infusion Therapy Market (US$ Bn), by Gastrointestinal Diseases/Disorders, 2017–2031
  • Figure 10 : Global Infusion Therapy Market (US$ Bn), by Congestive Heart Failure, 2017–2031
  • Figure 11 : Global Infusion Therapy Market (US$ Bn), by Rheumatoid Arthritis, 2017–2031
  • Figure 12 : Global Infusion Therapy Market (US$ Bn), by Hemophilia, 2017–2031
  • Figure 13 : Global Infusion Therapy Market (US$ Bn), by Immune Deficiencies, 2017–2031
  • Figure 14 : Global Infusion Therapy Market (US$ Bn), by Others, 2017–2031
  • Figure 15 : Global Infusion Therapy Market, by Therapy, 2021 and 2031
  • Figure 16 : Global Infusion Therapy Market Attractiveness Analysis, Therapy, 2022–2031
  • Figure 17 : Global Infusion Therapy Market (US$ Bn), by Antibiotic/Antiviral, 2017–2031
  • Figure 18 : Global Infusion Therapy Market (US$ Bn), by Anti-coagulation, 2017–2031
  • Figure 19 : Global Infusion Therapy Market (US$ Bn), by Anti-emetics, 2017–2031
  • Figure 20 : Global Infusion Therapy Market (US$ Bn), by Blood Component Stimulating Factor, 2017–2031
  • Figure 21 : Global Infusion Therapy Market (US$ Bn), by Chemotherapy, 2017–2031
  • Figure 22 : Global Infusion Therapy Market (US$ Bn), by Nutrition, 2017–2031
  • Figure 23 : Global Infusion Therapy Market (US$ Bn), by Hydration, 2017–2031
  • Figure 24 : Global Infusion Therapy Market (US$ Bn), by Pain Management, 2017–2031
  • Figure 25 : Global Infusion Therapy Market, by End-user, 2021 and 2031
  • Figure 26 : Global Infusion Therapy Market Attractiveness Analysis, End-user, 2022–2031
  • Figure 27 : Global Infusion Therapy Market (US$ Bn), by Hospitals, 2017–2031
  • Figure 28 : Global Infusion Therapy Market (US$ Bn), by Ambulatory Surgical Centers, 2017–2031
  • Figure 29 : Global Infusion Therapy Market (US$ Bn), by Clinics, 2017–2031
  • Figure 30 : Global Infusion Therapy Market (US$ Bn), by Homecare Settings, 2017–2031
  • Figure 31 : Global Infusion Therapy Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 32 : Global Infusion Therapy Market Attractiveness Analysis, by Region, 2022–2031
  • Figure 33 : North America Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 34 : North America Infusion Therapy Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 35 : North America Infusion Therapy Market Attractiveness Analysis, by Country, 2022–2031
  • Figure 36 : North America Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 37 : North America Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 38 : North America Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
  • Figure 39 : North America Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031
  • Figure 40 : North America Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 41 : North America Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
  • Figure 42 : North America Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 43 : North America Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 44 : Europe Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 45 : Europe Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 46 : Europe Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 47 : Europe Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 48 : Europe Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 49 : Europe Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
  • Figure 50 : Europe Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031
  • Figure 51 : Europe Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 52 : Europe Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
  • Figure 53 : Europe Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 54 : Europe Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 55 : Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 56 : Asia Pacific Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 57 : Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 58 : Asia Pacific Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 59 : Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 60 : Asia Pacific Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
  • Figure 61 : Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031
  • Figure 62 : Asia Pacific Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 63 : Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
  • Figure 64 : Asia Pacific Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 65 : Asia Pacific Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 66 : Latin America Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 67 : Latin America Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 68 : Latin America Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 69 : Latin America Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 70 : Latin America Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 71 : Latin America Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
  • Figure 72 : Latin America Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031
  • Figure 73 : Latin America Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 74 : Latin America Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
  • Figure 75 : Latin America Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 76 : Latin America Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 77 : Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 78 : Middle East & Africa Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 79 : Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 80 : Middle East & Africa Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 81 : Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 82 : Middle East & Africa Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
  • Figure 83 : Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031
  • Figure 84 : Middle East & Africa Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 85 : Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
  • Figure 86 : Middle East & Africa Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 87 : Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Transparency
Price: $5795

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS